Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
…the UK.8 11Upon examination of the outbreak investigations with bacterial meningitis amongst patients undergoing spinal procedures where healthcare …
…50). The primary outcome was pain intensity, assessed using the Numeric Rating Scale (NRS) at 7 days, 30 days, 3 months, and 6 months. Secondary out…
…upivacaine[N= 10], 20 ml of 1% Lidocaine[N=12], 20 ml of 0.375% Ropivacaine[N=13]. Before and for 45 minutes after nerve block for every mi…
… with respiratory syncytial virus (RSV) bronchiolitis receiving dexmedetomidine (DMED). We aim to study the association between RSV bronchiolit…
…larifiedConclusion The incidence of POUR in older patients with hip fractures varies widely. Most factors were reported in one study with no …
…Objective Bronchopulmonary dysplasia (BPD) associated pulmonary hypertension (BPD-PH) is the most se…
…infection control. After restrictions were lifted, influenza A, influenza B and hRSV emerged rapidly, showing the importance of continuous …
…ical experiment, with participants randomised 1:1:1 to one of: ‘melanoma in-situ’ (control), ‘low-risk melanocytic neoplasm’, or ‘low-ri…
… adverse events of intensive lipid-lowering treatment including evolocumab and ezetimibe (triple therapy) after endovascular thrombectomy …
…ailed or refused to quit smoking after counselling were offered varenicline. Acceptance, compliance and adherence rates were determined.Res…
…s were the most commonly used medications (50.02%), followed by HMG-CoA reductase inhibitors (42.73%) and platelet aggregation inhibitors (41.92%). Polyphar…
…k (HR=0.677, 95% CI =0.638 to 0.719, p<0.001), particularly for Alzheimer’s disease (HR=0.643, 95% CI=0.576 to 0.716, p<0.001), with no significant…